News

Medical Device Network4h
First subject enrolled in trial of Medtronic’s liquid embolic system
Medtronic has announced the first subject enrolment in the PELE trial, aiming to assess the Onyx liquid embolic system (LES).
MassDevice21h
Medtronic enrolls first patient in study for Onyx liquid embolic system
Medtronic (NYSE: MDT) today announced the first patient enrolled in the PELE trial of its Onyx liquid embolic system (LES).